Department of Cardiology and Cardiovascular Medicine, University Hospital, Eberhard Karls University Tuebingen, Otfried-Mueller-Straße 10, 72076 Tuebingen, Germany.
Department of Anaesthesiology, University Hospital, Eberhard Karls University Tuebingen, Hoppe-Seyler-Straße 3, 72076 Tuebingen, Germany.
Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):785-791. doi: 10.1093/ehjci/jex173.
Improved mitral valve leaflet coaptation with consecutive reduction of mitral regurgitation (MR) is a central goal of percutaneous mitral valve repair (PMVR) with the MitraClip® system. As influences of PMVR on mitral valve geometry have been suggested before, we examined the effect of the procedure on mitral annular size in relation to procedural outcome.
Geometry of the mitral valve annulus was evaluated in 183 patients undergoing PMVR using echocardiography before and after the procedure and at follow-up. Mitral valve annular anterior-posterior (ap) diameter decreased from 34.0 ± 4.3 to 31.3 ± 4.9 mm (P < 0.001), and medio-lateral (ml) diameter from 33.2 ± 4.8 to 32.4 ± 4.9 mm (P < 0.001). Accordingly, we observed an increase in MV leaflet coaptation after PMVR. The reduction of mitral valve ap diameter showed a significant inverse correlation with residual MR. Importantly, the reduction of mitral valve ap diameter persisted at follow-up (31.3 ± 4.9 mm post PMVR, 28.4 ± 5.3 mm at follow-up).
This study demonstrates mechanical approximation of both mitral valve annulus edges with improved mitral valve annular coaptation by PMVR using the MitraClip® system, which correlates with residual MR in patients with MR.
通过经皮二尖瓣修复术(PMVR)使用 MitraClip®系统,改善二尖瓣瓣叶对合,连续降低二尖瓣反流(MR)是该治疗的核心目标。由于之前已经提出 PMVR 对二尖瓣几何形状的影响,我们研究了该手术对二尖瓣环大小与手术结果的关系。
对 183 例接受 PMVR 的患者,术前、术后和随访时使用超声心动图评估二尖瓣瓣环的几何形状。二尖瓣瓣环前后(ap)直径从 34.0±4.3 降至 31.3±4.9mm(P<0.001),中-外侧(ml)直径从 33.2±4.8 降至 32.4±4.9mm(P<0.001)。因此,我们观察到 PMVR 后二尖瓣瓣叶对合增加。PMVR 后二尖瓣瓣环 ap 直径的减小与残余 MR 呈显著负相关。重要的是,二尖瓣瓣环 ap 直径的减小在随访时仍然存在(PMVR 后 31.3±4.9mm,随访时 28.4±5.3mm)。
本研究表明,PMVR 使用 MitraClip®系统可以使二尖瓣瓣环边缘机械性接近,改善二尖瓣瓣环对合,与 MR 患者的残余 MR 相关。